Literature DB >> 33143022

Malignant Ependymoblastoma Mimicking a Benign Pilocytic Astrocytoma.

Pham Minh Thong1, Nguyen Minh Duc1,2,3.   

Abstract

Ependymoblastoma is an uncommon, exceedingly malignant brain neoplasm that adversely influences children's quality of life. Ependymoblastoma represents a subtype of primitive neuroectodermal tumors, categorized as grade IV, according to the 2007 World Health Organization (WHO) classification of central nervous system tumors. Ependymoblastomas are often located in the supratentorial zone and often associated with the ventricular system. Histopathological sections of the tumor revealed uniform, primitive, small blue cells, with multi-layered rosettes, accompanied by abundant mitoses. The clinical and imaging features of ependymoblastomas are not specific, which can result in misdiagnosis as other brain neoplasms. In this paper, we described the identification of a fourth-ventricular ependymoblastoma that was misdiagnosed as pilocytic astrocytoma, despite the utilization of advanced magnetic resonance imaging (MRI) protocols.

Entities:  

Keywords:  children; ependymoblastoma; fourth ventricle tumor; pilocytic astrocytoma

Year:  2020        PMID: 33143022      PMCID: PMC7768421          DOI: 10.3390/neurolint12030010

Source DB:  PubMed          Journal:  Neurol Int        ISSN: 2035-8385


  12 in total

1.  Sacrococcygeal ependymoblastoma.

Authors:  Andrew P Gard; Deborah A Perry; Shahab Abdessalam; Bradley S Bowdino
Journal:  Childs Nerv Syst       Date:  2015-10-22       Impact factor: 1.475

2.  The definition of the ependymoblastoma.

Authors:  L J Rubinstein
Journal:  Arch Pathol       Date:  1970-07

3.  Ependymoblastoma in an adult: a diagnostic challenge on cytology.

Authors:  Sonal Amit; Priyanka Chand; Chayanika Pantola; Asha Agarwal
Journal:  BMJ Case Rep       Date:  2011-11-08

4.  Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified.

Authors:  Johannes Nowak; Carolin Seidel; Torsten Pietsch; Balint Alkonyi; Taylor Laura Fuss; Carsten Friedrich; Katja von Hoff; Stefan Rutkowski; Monika Warmuth-Metz
Journal:  Neuro Oncol       Date:  2015-04-26       Impact factor: 12.300

5.  Ependymoblastoma. A reappraisal of a rare embryonal tumor.

Authors:  S J Mørk; L J Rubinstein
Journal:  Cancer       Date:  1985-04-01       Impact factor: 6.860

Review 6.  Fetal brain tumors: a review of 154 cases.

Authors:  Hart Isaacs
Journal:  Am J Perinatol       Date:  2009-04-24       Impact factor: 1.862

Review 7.  Neuroectodermal ovarian tumors: a brief overview.

Authors:  Anamarija Morovic; Ivan Damjanov
Journal:  Histol Histopathol       Date:  2008-06       Impact factor: 2.303

8.  Ependymoblastoma with cystic change in a child.

Authors:  Daling Ding; Ailing Zhao; Bo Qiu; Deguang Xing; Gefei Guan; Zongze Guo
Journal:  J Neurosurg Pediatr       Date:  2014-04-11       Impact factor: 2.375

Review 9.  A Simplified Overview of World Health Organization Classification Update of Central Nervous System Tumors 2016.

Authors:  Anshu Gupta; Tanima Dwivedi
Journal:  J Neurosci Rural Pract       Date:  2017 Oct-Dec

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  2 in total

1.  Ependymoblastoma with pulmonary metastasis in an adolescent: A case report.

Authors:  Xinmin Xu; Angcheng Li; Xia Xu; Qiangjun Gong; Shengjie Zhu; Wenya Chu; Shubo Ding
Journal:  Front Neurol       Date:  2022-08-09       Impact factor: 4.086

2.  Morphogenetic and Imaging Characteristics in Giant Cell Glioblastoma.

Authors:  Cristian Ionut Orasanu; Mariana Aschie; Mariana Deacu; Liliana Mocanu; Raluca Ioana Voda; Theodor Sebastian Topliceanu; Georgeta Camelia Cozaru
Journal:  Curr Oncol       Date:  2022-07-28       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.